Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-27

Clinical Trial Update: A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated veliparib as a single agent or in combination with chemotherapy in adults with solid tumors and has completed, including patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Breast Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED